Supply of nuclear medicine in the news
Lutetium-177 used for advanced prostate cancer
Showing 1 - 20 of 512 results
Lutetium-177 used for advanced prostate cancer
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.
Routine transport of spent nuclear fuel
During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).
ANSTO has hosted an event to launch a new Dharawal language learning resource for primary students at the nandin innovation centre.
SVSR is seeking a highly motivated engineering candidate with excellent communication skills to help better understand and manage odour emission from sewer ventshafts.
Three-year full-time PhD program is in partnership between the nandin Innovation Centre (ANSTO) and Design Factory Melbourne (Swinburne University). The PhD is based at ANSTO, Lucas Heights, Sydney, NSW.
The release of the Oppenheimer film, the story of the director of the Manhattan Project, has prompted many people to go online and search for an explanation of the difference between fission and fusion, two fundamental scientific concepts.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
ANSTO is part of collaboration conducting experiments to redefine the kilogram linking it to a fundamental constant of nature.
ANSTO showcased its significant contribution to security, safety, and public health during a visit of the Director-General of the International Atomic Energy Agency (IAEA) Rafael Grossi, Minister for Industry and Science Ed Husic, Australian Ambassador to Austria Richard Sinclair and Ambassador for Arms Control and Counter-Proliferation Ian Biggs and other dignitaries at the weekend.
See details of previously published customer updates from our Health products team.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Read about an ANSTO scientist and their work to prepare for a school project or interview.